Abstract
Urinary stones are polycrystalline aggregates consisting of varying amounts of crystal and organic matrix components. Although urolithiasis is inclusive of renal, ureteral, and bladder stones, the following discussion will pertain only to symptomatic renal and ureteral stones, as they are the most common. The most common urinary stone types are calcium oxalate, calcium phosphate, uric acid, struvite (magnesium ammonium phosphate), and cystine. In an analysis of 14,557 renal and ureteral stones, 52% were purely calcium oxalate, 13% purely calcium phosphate, 15% a mixture of calcium oxalate and phosphate, 4% struvite, 8% uric acid, and 8% other compounds (1). As the majority of stones are of the calcium variety, it is likely that most epidemiological studies of nephrolithiasis pertain to this compositional form. Of the less common stone varieties, struvite stones are commonly associated with urinary tract infections, most notably secondary to urease splitting organisms such as Proteus and Klebsiella. Uric acid stones, associated with hyperuricosuric patients, are found in patients with gout, dehydration, and excessive purine intake. Finally, cystine stones are a rare form associated with inborn errors of metabolism resulting in abnormal absorption of dibasic amino acids in the small bowel and proximal renal tubule.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gault MH, Chafe L. Relationship of frequency, age, sex, stone weight and composition in 15,624 Stones: comparisons of results for 1980–1983 and 1995–1998. J Urol 2000; 164: 302–307.
Reiter WJ, Schon-Pernerstorfer H, Dorfinger K, Hofbauer J, Marberger M. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed. J Urol 1999; 161: 1082–1084.
Indavir Sulfate (Crixivan) package insert. Merck and Co., West Point Pennsylvania, PA 1996.
Wu DS, Stoller ML. Indinavir urolithiasis. Current Opinion Urol 2000; 10: 557–561.
Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kid Int 1979; 16: 624–631.
Curhan GC, Rimm EB, Willet WC, Stampfer MJ. Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol 1994; 151: 838–841.
Curhan GC, Curhan SG. Diet and urinary stone disease. Current Op Urol 1997; 7: 222.
Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron 1999; 81S: 26–30.
Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965–1995. Kid Int 1999; 56: 1899–1904.
Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kid Int 1994; 46: 893–899.
Gault MH, Chafe L. Relationship of frequency, age, sex, stone weight and composition in 15,624 stones: comparisons of results for 1980–1983 and 1995–1998. J Urol 2000; 164: 302–307.
Curhan GC, Willett WC, Peizer FE, Stampfer MJ. Twenty-four hour urine chemistries and the risk of kidney stones among women and men. Kid Int 2001; 59: 2290–2298.
Michaels EK, Nakagawa Y, Miura N, Pursell S, Ito H. Racial variation in gender frequency of calcium urolithiasis. J Urol 1994; 152: 2228–2231.
Soucie JM, Coates RJ, McClellan W, Austin H, Thun M. Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epi 1996;143(5): 487–495.
Hall WD, Pettinger M, Oberman A, et al. Risk factors for kidney stones in older women in the Southern United States. Am J Med Sci 2001; 322(1): 12–18.
Borghi L, Meschi T, Amato F, Novarini A, Romanelli A, Cigala F. Hot occupation and nephrolithiasis. J of Urol 1993; 50: 1757–1760.
Nguyen QV, Kalin A, Drouve U, Casez JP, Jaeger P. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers. Kid Int 2001; 59(6): 2273–2281.
Hiatt RA, Ettinger B, Caan B, Quessenberry CP, Duncan D, Citron J. Randomized control trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 1996; 144: 25.
Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B. Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epi 1998; 147(10): 914–920.
Curhan GC, Willet WC, Rimm EB, Stampher MJ. Aprospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Eng J Med 1993; 328: 833.
Curhan GC, Curhan SG. Diet and urinary stone disease. Current Op Urol 1997; 7: 222.
Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB. Unraveling the links between calcium excretion, salt intake, hypertension, kidney stones, and bone metabolism. J Neprhol 2000; 13: 3, 169–177.
Borghi L, Schiani T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Eng J Med 2002; 346: 77–84.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 810, 1568–1573.
Goodman HO, Brommage R, Assimos DG, Holmes RP. Genes in idiopathic calcium oxalate stone disease. World J Urol 1997; 153, 186–194.
Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW. Familial calcium stone disease: Taql polymorphism and the vitamin D receptor. J Endourology 1999; 134, 313–316.
Borghi L, Meschi T, Guerra A, et al. A. Essential hypertension and stone disease. Kid Int 1999; 55: 2397–2406.
Santos-Vistoriano M, Brouchard BH, Cunningham III, RJ. Renal stone disease in children. Clin Ped 1998; 37: 583–600.
Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor. J Urol 2000; 164: 162–165.
Swanson SK, Heilman RL, Eversman WG. Urinary tract stones in pregnancy. Surg Clin N Amer 1995; 75(1): 123–142.
Butler EL, Cox SM, Eberts EG, Cunningham FG. Symptomatic nephrolithiasis complicating pregnancy. Ob Gyn 2000; 96(5): 753–756.
Chen YY, Roseman JM, DeVivo MJ, Huang CT. Geographic variation and environmental risk factors for the incidence of initial kidney stones in patients with spinal cord injury. J Urol. 2000; 164: 21–26.
Chen Y, DeVivo MJ, Roseman JM. Current trend and risk factors for kidney stones in persons with spinal cord injury: a longitudinal study. Spinal Cord 2000; 38: 346–353.
Sun BY-C, Lee YH, Jiaan, BP, Chen KK, Chang LS, Chen KT. Recurrence rate and risk factors for urinary calculi after extracorporeal shock wavy lithotripsy. J Urol 1996; 156: 903.
Kamihira O, Ono Y, Katoh N, Yamada S, Mizutani K, Ohshima S. Long-term stone recurrence rate after extracorporeal shock wave lithotripsy. J Urol 1996; 156: 1267–1271.
Carr LK, Honey RJD, Jewett MAS, Ibanez D, Ryan M, Bombardier C. New stone formation: a comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. J Urol 1996; 155: 1565–1567.
Fine JK, Pak CYC, Preminger GM. Effect of medical management and residual fragments on recurrent stone formation following shockwave lithotripsy. J Urol 1995; 153: 27–33.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this chapter
Cite this chapter
Dallera, J.E., Chandhoke, P.S. (2007). Epidemiology and Incidence of Stone Disease. In: Stoller, M.L., Meng, M.V. (eds) Urinary Stone Disease. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59259-972-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-972-1_2
Publisher Name: Humana Press
Print ISBN: 978-1-58829-219-3
Online ISBN: 978-1-59259-972-1
eBook Packages: MedicineMedicine (R0)